Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence.

Vardar E, Vythilingam G, Pinnagoda K, Engelhardt EM, Zambelli PY, Hubbell JA, Lutolf MP, Frey P, Larsson HM.

Biomaterials. 2019 Jun;206:41-48. doi: 10.1016/j.biomaterials.2019.03.030. Epub 2019 Mar 20.

PMID:
30925287
2.

Quantitative intrinsic auto-cathodoluminescence can resolve spectral signatures of tissue-isolated collagen extracellular matrix.

Zielinski MS, Vardar E, Vythilingam G, Engelhardt EM, Hubbell JA, Frey P, Larsson HM.

Commun Biol. 2019 Feb 18;2:69. doi: 10.1038/s42003-019-0313-x. eCollection 2019.

3.

Fiber density of collagen grafts impacts rabbit urethral regeneration.

Larsson HM, Vythilingam G, Pinnagoda K, Vardar E, Engelhardt EM, Sothilingam S, Thambidorai RC, Kamarul T, Hubbell JA, Frey P.

Sci Rep. 2018 Jul 3;8(1):10057. doi: 10.1038/s41598-018-27621-9.

4.

Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment.

Vardar E, Larsson HM, Allazetta S, Engelhardt EM, Pinnagoda K, Vythilingam G, Hubbell JA, Lutolf MP, Frey P.

Acta Biomater. 2018 Feb;67:156-166. doi: 10.1016/j.actbio.2017.11.034. Epub 2017 Nov 29.

PMID:
29197579
5.

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events.

Ishihara J, Fukunaga K, Ishihara A, Larsson HM, Potin L, Hosseinchi P, Galliverti G, Swartz MA, Hubbell JA.

Sci Transl Med. 2017 Nov 8;9(415). pii: eaan0401. doi: 10.1126/scitranslmed.aan0401.

PMID:
29118259
6.

Is tissue engineering of patient-specific oral mucosa grafts the future of urethral reconstruction?

Larsson HM.

EBioMedicine. 2017 Oct;24:30-31. doi: 10.1016/j.ebiom.2017.09.006. Epub 2017 Sep 8. No abstract available.

7.

Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials.

Briquez PS, Lorentz KM, Larsson HM, Frey P, Hubbell JA.

Biomaterials. 2017 Aug;135:1-9. doi: 10.1016/j.biomaterials.2017.04.048. Epub 2017 Apr 29.

8.

Engineered acellular collagen scaffold for endogenous cell guidance, a novel approach in urethral regeneration.

Pinnagoda K, Larsson HM, Vythilingam G, Vardar E, Engelhardt EM, Thambidorai RC, Hubbell JA, Frey P.

Acta Biomater. 2016 Oct 1;43:208-217. doi: 10.1016/j.actbio.2016.07.033. Epub 2016 Jul 19.

PMID:
27450527
9.

IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering.

Vardar E, Larsson HM, Engelhardt EM, Pinnagoda K, Briquez PS, Hubbell JA, Frey P.

Acta Biomater. 2016 Sep 1;41:75-85. doi: 10.1016/j.actbio.2016.06.010. Epub 2016 Jun 7.

PMID:
27286676
10.

Tubular Compressed Collagen Scaffolds for Ureteral Tissue Engineering in a Flow Bioreactor System.

Vardar E, Engelhardt EM, Larsson HM, Mouloungui E, Pinnagoda K, Hubbell JA, Frey P.

Tissue Eng Part A. 2015 Sep;21(17-18):2334-45. doi: 10.1089/ten.TEA.2015.0048. Epub 2015 Jul 20.

PMID:
26065873
11.

Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine.

Martino MM, Brkic S, Bovo E, Burger M, Schaefer DJ, Wolff T, G├╝rke L, Briquez PS, Larsson HM, Gianni-Barrera R, Hubbell JA, Banfi A.

Front Bioeng Biotechnol. 2015 Apr 1;3:45. doi: 10.3389/fbioe.2015.00045. eCollection 2015. Review.

12.

Clonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population.

Larsson HM, Gorostidi F, Hubbell JA, Barrandon Y, Frey P.

PLoS One. 2014 Feb 26;9(2):e90006. doi: 10.1371/journal.pone.0090006. eCollection 2014.

13.

Sorting live stem cells based on Sox2 mRNA expression.

Larsson HM, Lee ST, Roccio M, Velluto D, Lutolf MP, Frey P, Hubbell JA.

PLoS One. 2012;7(11):e49874. doi: 10.1371/journal.pone.0049874. Epub 2012 Nov 27.

Supplemental Content

Loading ...
Support Center